Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ABN AMRO Asset Management was the global investment management arm of the Netherlands-based ABN AMRO Bank. The firm provided a comprehensive suite of investment solutions, including equities, fixed income, and alternative investments, to institutional and private clients worldwide. While primarily a financial institution, the firm was a significant player in the life sciences sector through its specialized healthcare and biotechnology investment funds, such as the ABN AMRO Bio-Equity Fund. In 2008, following the breakup of ABN AMRO, the asset management division was acquired by Fortis Investments, which was subsequently integrated into BNP Paribas Asset Management. Today, the legacy of its healthcare investment expertise continues within the broader BNP Paribas framework and ABN AMRO's remaining corporate banking healthcare desk.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ABN AMRO Asset Management.